Ozempic is also approved to reduce the risk of major adverse cardiovascular events, including cardiovascular death, heart attack, and stroke, in adults with type 2 diabetes and known cardiovascular disease
The WISeR (Wasteful and Inappropriate Services Reduction) model is a Medicare Part B prior authorization pilot running from January 2026 through December 2031 in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington
Is there less of a weight loss response for those with lower BMI
While effective for glycemic control and weight management, these mechanisms can limit nutrient intake and affect absorption
By eight weeks, most patients have lost about 4% of their starting body weight